Clinical trials
Cholangiocarcinoma trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 10 |
| Recruiting | 6 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First People's Hospital of Hangzhou | 6 |
| First Affiliated Hospital Xi'an Jiaotong University | 4 |
| Eastern Hepatobiliary Surgery Hospital | 3 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 |
| Shengjing Hospital | 2 |
| Tianjin Medical University Cancer Institute and Hospital | 2 |
| 307 Hospital of PLA | 1 |
| Bing Hu | 1 |
| China Medical University, China | 1 |
| Hepatopancreatobiliary Surgery Institute of Gansu Province | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 31 |
| Carcinoma, Hepatocellular | 6 |
| Pancreatic Neoplasms | 6 |
| Biliary Tract Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Cysts | 2 |
| Duodenal Neoplasms | 2 |
| Focal Nodular Hyperplasia | 2 |
| Ovarian Neoplasms | 2 |
| Pancreatitis, Chronic | 2 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.